rs587783672
|
|
T |
0.720 |
CausalMutation |
CLINVAR |
|
|
|
rs193929355
|
|
T |
0.710 |
CausalMutation |
CLINVAR |
|
|
|
rs80356625
|
|
A |
0.710 |
CausalMutation |
CLINVAR |
|
|
|
rs1057515576
|
|
GAAAA |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1057518903
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1135401784
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs1553769428
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs1559279177
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs28936415
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs386134141
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs587783669
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs587783673
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587783675
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs886040857
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs498005
|
|
|
0.010 |
GeneticVariation |
BEFREE |
<b>Results:</b> C allele of rs498005 was significantly correlated with increased risk of AF (OR = 1.412, 95%CI = 1.012-1.970), and the association still exited after adjustment by age, gender, the status of smoking and drinking, histories of diabetes, hyperlipidaemia and myocardial infarction (adjusted OR = 1.473, 95%CI = 1.043-2.081).
|
31315459 |
2019 |
rs5215
|
|
|
0.020 |
GeneticVariation |
BEFREE |
48% and 47% had 1 or 2 diabetes risk alleles of rs5215 and rs5219, respectively.
|
30169531 |
2018 |
rs12255372
|
|
|
0.090 |
GeneticVariation |
BEFREE |
Diabetes disease stage was marginally significantly associated with the frequency of the T variant at rs12255372 (p=0.057; adjusted p=0.017) but not at rs7903146 (p=0.5; adjusted p=0.2).
|
18282631 |
2008 |
rs7903146
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Diabetes disease stage was marginally significantly associated with the frequency of the T variant at rs12255372 (p=0.057; adjusted p=0.017) but not at rs7903146 (p=0.5; adjusted p=0.2).
|
18282631 |
2008 |
rs7903146
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Diabetes-associated variation (T allele at rs7903146) in TCF7L2 may impair the ability of hyperglycemia to suppress glucagon (45 ± 2 vs. 47 ± 2 vs. 60 ± 5 ng/L for CC, CT, and TT, respectively, P = 0.02).
|
22461567 |
2012 |
rs1801282
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Diabetes risk alleles in PPAR-γ2 (rs1801282) and PTPRD (rs17584499) are associated with pioglitazone therapeutic efficacy.
|
23147557 |
2013 |
rs17584499
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Diabetes risk alleles in PPAR-γ2 (rs1801282) and PTPRD (rs17584499) are associated with pioglitazone therapeutic efficacy.
|
23147557 |
2013 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Diabetes mellitus and late-onset hypogonadism: the role of Glu298Asp endothelial nitric oxide synthase polymorphism.
|
25228279 |
2015 |
rs1036483919
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The heterozygous T130I mutation was the unique functional gene variation that could explain diabetes phenotype.
|
25361053 |
2014 |
rs952497863
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The heterozygous T130I mutation was the unique functional gene variation that could explain diabetes phenotype.
|
25361053 |
2014 |
rs2228570
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Diabetes duration, SBP, HbA1c, and the rs2228570 T allele were associated with increased risk of DR. VDR rs2228570 might be good candidate biomarker of DR in Han Chinese T2DM patients.
|
25899017 |
2015 |